Tuukka Paavola
CFO, Nightingale Health
Replay available
Nightingale Health Oyj (OTC: NGHLF) Q4 2025 earnings conference call, held 2025-09-18. Replay captured from the company's public earnings webcast.

CFO, Nightingale Health
CEO and Founder, Nightingale Health
webcast for the full year results. So today our agenda is that I will start by talking about our technology and products. Then we move to the business targets of the past fiscal year. Then we will have a look at the key achievements. Then we have financial review. And then Tuukka-Paavola, our CFO, will join me on stage for that part. Then we have business targets for the ongoing fiscal year. Then we have the financial calendar and AGM. Then I will be talking about some significant events after the end of the period. And then in the end, we have a Q&A. Our chief operating officer, Rianna Ranta, will join us on stage for the Q&A. Please post your questions. My name is Teemu Suna. I'm CEO and founder of Nightingale Health. So let's start. So why Nightingale exists? We exist to build better healthcare for everyone. And now when I say everyone, I mean everyone. I mean citizens, I mean healthcare professionals, I mean institutions, I mean taxpayers, I mean everyone. And this is all about solving healthcare's biggest challenge. So why do we need to solve healthcare challenges? Well, if you look at healthcare, the big picture, the costs of healthcare are up to 18% of gross domestic product. And to give a bit of context, this is around four times more than military spending. And this applies, the top-line percentage is different in different countries, but the ratio is pretty much the same. It's also not only about money. So... the way how healthcare is organized today also causes suffering. So we live longer than ever, yet we are sicker than ever. So if you look at this in a bit more detail, 75% of all deaths globally are caused by preventable chronic diseases. The chronic diseases, they cost tens of trillions of dollars globally. And then if we look to the future, it's not ...